New User? Sign Up | Sign In

Insider Trading - Thackray Helen M.

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

Insider Trading Transactions for Thackray Helen M.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-10-03
Sale
2016-10-04
4:22 pm
GLYCOMIMETICS INC GLYC Thackray Helen M.
VP Clinical Development CMO
4,000 $7.0003 $28,001 156,615
(Direct)
View
2017-05-19
Sale
2017-05-22
9:23 pm
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
2,000 $12.14 $24,280 154,615
(Direct)
View
2017-05-25
Sale
2017-05-30
4:07 pm
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
2,000 $15.57 $31,140 152,615
(Direct)
View
2017-09-18
Sale
2017-09-18
6:15 pm
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
2,000 $13 $26,000 150,615
(Direct)
View
2017-12-08
Sale
2017-12-12
4:14 pm
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
2,000 $15.01 $30,020 148,615
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-01-04
Option Award
2017-01-05
08:51 am
N/A
2027-01-03
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
75,000 $0 75,000
(Direct)
View
2018-01-10
Option Award
2018-01-12
4:04 pm
N/A
2028-01-09
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
75,000 $0 75,000
(Direct)
View
2019-01-17
Option Award
2019-01-22
6:20 pm
N/A
2029-01-16
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
100,000 $0 100,000
(Direct)
View
2019-09-20
Option Award
2019-09-24
4:27 pm
2020-09-20
2029-09-20
BIOCRYST PHARMACEUTICALS INC BCRX Thackray Helen M.
Director
40,000 $0 40,000
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:17 pm
N/A
2030-01-21
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
120,000 $0 120,000
(Direct)
View
2020-05-12
Option Award
2020-05-14
4:36 pm
2021-05-12
2030-05-12
BIOCRYST PHARMACEUTICALS INC BCRX Thackray Helen M.
Director
40,000 $0 40,000
(Direct)
View
2021-01-20
Option Award
2021-01-22
4:05 pm
N/A
N/A
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
34,500 $0 183,115
(Direct)
View
2021-01-20
Option Award
2021-01-22
4:05 pm
N/A
2031-01-19
GLYCOMIMETICS INC GLYC Thackray Helen M.
SVP Clinical Development CMO
69,000 $0 69,000
(Direct)
View
2021-03-31
Option Award
2021-04-02
5:26 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX Thackray Helen M.
Chief R&D Officer
100,000 $0 100,000
(Direct)
View
2021-03-31
Option Award
2021-04-02
5:26 pm
2022-03-31
2031-03-31
BIOCRYST PHARMACEUTICALS INC BCRX Thackray Helen M.
Chief R&D Officer
400,000 $0 400,000
(Direct)
View